These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pharmacological studies on timiperone, a new neuroleptic drug Part II: General pharmacological properties. Yamasaki T, Kojima H, Tanaka M, Aibara S, Hirohashi M, Kasai Y, Tsubokawa M, Watanabe K, Akashi A. Arzneimittelforschung; 1981; 31(4):707-15. PubMed ID: 6113834 [Abstract] [Full Text] [Related]
3. [Central effect of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride]. Hukuhara T, Otsuka Y, Takeda R, Sukai F. Arzneimittelforschung; 1968 Sep; 18(9):1147-53. PubMed ID: 5755929 [No Abstract] [Full Text] [Related]
5. Pharmacological and toxicological studies of binodaline hydrochloride. Jahn U, Adrian RW, Ismail S, Michos N. Arzneimittelforschung; 1983 Sep; 33(5):726-39. PubMed ID: 6683551 [Abstract] [Full Text] [Related]
6. [Immediate effect of 2-(2,6-dichlorophenylamino)-imidazoline (ST 155) on diuresis and renal blood output in dogs]. Barac G. C R Seances Soc Biol Fil; 1970 Sep; 164(11):2406-9. PubMed ID: 4257384 [No Abstract] [Full Text] [Related]
7. [Chemical and pharmacological study of new derivatives of noradrenaline]. Régnier G, Canevari R, Laubie M, Le Douarec JC. Arzneimittelforschung; 1969 Oct; 19(10):1698-702. PubMed ID: 5395370 [No Abstract] [Full Text] [Related]
8. [Effect of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155, Catapresan) on the urinary excretion of osmotically free water]. Kobinger W. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968 Oct; 260(2):153-4. PubMed ID: 4239193 [No Abstract] [Full Text] [Related]
11. [Pharmacologic properties of hydrazine derivatives of methylxanthines]. Krupińska J. Folia Med Cracov; 1970 Jun; 12(2):251-83. PubMed ID: 5433429 [No Abstract] [Full Text] [Related]
12. Pharmacological research on some 1,5-bis-(3,4--methylendioxyphenyl)-n.pentane derivatives. Agozzino S, Benigni F, Molinari ML, Zoni G, Di Carlo R. Farmaco Sci; 1978 Mar; 33(3):159-88. PubMed ID: 570125 [No Abstract] [Full Text] [Related]
14. General pharmacological profile of the new cognition-enhancing agent nefiracetam. Kitano Y, Makino M, Usui C, Takasuna K, Kasai Y, Hirohashi M, Tamura K, Takayama S, Kojima H, Iizuka H. Arzneimittelforschung; 1994 Feb; 44(2A):199-210. PubMed ID: 8018090 [Abstract] [Full Text] [Related]
15. General pharmacology of the new non-xanthine adenosine A1 receptor antagonist (+)-(R)-[(E)-3-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)acryloyl]-2- piperidine ethanol. Terai T, Kusunoki T, Kita Y, Yoshida K, Akahane A, Shiokawa Y, Kohno Y, Horiai H, Mori J, Mine Y, Kohsaka M. Arzneimittelforschung; 1996 Feb; 46(2):185-91. PubMed ID: 8720311 [Abstract] [Full Text] [Related]
18. [The effect of 2-(2,6-dichlorophenylamino)-2-imidazoline-hydrochloride on the EEG arousal reaction in rabbits]. Gogolák G, Stumpf C. Arzneimittelforschung; 1966 Aug; 16(8):1050-2. PubMed ID: 6014886 [No Abstract] [Full Text] [Related]
19. Studies on a new analeptic agent, centphenaquin (11-N4-phenylpiperazine)-7,8,9,10-tetrahydro-6H-cyclohepta[b]qui noline dihydrochloride): Part II. Other pharmacological effects. Patnaik GK, Dhawan BN. Indian J Exp Biol; 1985 Apr; 23(4):214-8. PubMed ID: 2867031 [No Abstract] [Full Text] [Related]